The risk of dementia in relation to statins and other lipid lowering agents. (Q35540369)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14503013%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

0 references

1 reference

title

The risk of dementia in relation to statins and other lipid lowering agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14503013%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14503013%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1

Kenneth Rockwood

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14503013%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14503013%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

published in

Neurological Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14503013%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14503013%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14503013%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

601-604

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14503013%20AND%20SRC:MED&resulttype=core&format=json

A population-based study of dementia in 85-year-olds.

19 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Presence and treatment of vascular risk factors in patients with vascular cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Use of lipid-lowering drugs in older adults with and without dementia: a community-based epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Peroxisome proliferator-activated receptors: from genes to physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Mechanism of action of niacin on lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Structural mechanism for statin inhibition of HMG-CoA reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Cleavage of amyloid beta peptide during constitutive processing of its precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Purification and cloning of amyloid precursor protein beta-secretase from human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

15-year longitudinal study of blood pressure and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164103101202039

10.1179/016164103101202039

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14503013%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference